MT-1 / MELANOTAN I SAFETY
Melanotan 1 Side Effects: The SCENESSE Data
Side effects reported for the approved afamelanotide implant
⚠ Because melanotan 1 increases pigmentation, monitoring of moles and pigmented skin lesions is advised in the approved product's use.
Melanotan 1 side effects are best documented through its approved pharmaceutical form, afamelanotide (SCENESSE). For how it works, see the melanotan 1 mechanism page.
Reported Effects
Commonly reported effects for the approved implant included implant-site reactions, nausea, headache, and fatigue. Because the compound increases skin pigmentation, the label advises monitoring of the skin, including moles and pigmented lesions.
Source: FDA prescribing information for SCENESSE (afamelanotide).
Important Context
These effects were characterized for a clinician-administered implant in a rare disease. Injectable research-labeled "MT-1" is not that product and has not been evaluated by the FDA for safety.
Frequently Asked Questions
What did SCENESSE trials report as side effects?
Implant-site reactions, nausea, headache, and fatigue, with skin/pigment monitoring advised.
Is research-labeled MT-1 the same safety profile?
No. It is not the approved product and has not been FDA-evaluated for safety.
The Bottom Line
Melanotan 1 side effects, based on the approved afamelanotide product, include implant-site reactions, nausea, and a need for skin monitoring — and research-labeled melanotan 1 side effects are simply not FDA-characterized.
This article is for general educational purposes only. It is not medical advice and should not be used to diagnose, treat, or make decisions about any health condition or medication.
Primary Sources
- FDA prescribing information for SCENESSE (afamelanotide)
Wellness should feel clear, personal, and supported.
Start with education, ask the right questions, and take the next step with confidence.
Get in touch →